(The Dossier) — A Centers for Disease Control and Prevention (CDC) committee will convene this week and likely vote Thursday to deliver permanent legal indemnity to Pfizer and Moderna, through the process of adding the drug companies’ mRNA injections to the child and adolescent immunization schedules.
By adding the shots to the childhood schedule, the CDC’s Advisory Committee on Immunization Practices (ACIP) will transfer liability for vaccine injuries to the federal government’s National Vaccine Injury Compensation Program (VICP), allowing for Pfizer and Moderna to finally bring an FDA-approved shot to the market without opening itself up to lawsuits. Moreover, it will act as another windfall for companies that have already brought in hundreds of billions of dollars in revenues, by requiring these vaccinations for children who attend public schools.
🚩 CDC is trying to quietly include a vote to add the mRNA C•19 vaccine to the annual childhood immunization schedule. This vote takes place in 2 days on October 19th. Here’s why this matters:pic.twitter.com/NyaO1p0mAi
— Kate (@KateTalksTruth) October 17, 2022
In March 2020, the federal government invoked the PREP Act, which gave Pfizer and Moderna a tort liability shield due to the declared “public health emergency,” which the government is reportedly going to revoke in early 2023.
The companies’ emergency use authorization shots have since been protected by the federal government through this 2005 congressional action.
A draft agenda published by the CDC shows what will be on the schedule for Wednesday and Thursday’s meetings.
A @CDCgov official also said this at a recent webinar:
“stay tuned for next week’s ACIP meeting that will be discussed about the COVID-19 vaccines appearing on the child, and adolescent– child, adolescent, and adult schedules”https://t.co/Ka7CO5azaJhttps://t.co/eVsuM0TrzF pic.twitter.com/WFD8jyzCx0
— Alexander Tin (@Alexander_Tin) October 17, 2022
The Health Resources & Services Administration has clarified what needs to happen for a vaccine to become liability free:
For a vaccine to be covered, the Centers for Disease Control and Prevention (CDC) must recommend the category of vaccine for routine administration to children or pregnant women, and it must be subject to an excise tax by federal law.
The Dossier has reported extensively on the coordinated effort by Big Pharma and the Biden Administration to delay the rollout of an FDA approved COVID vaccine, with legal experts suspecting the process is in place to protect Pfizer and Moderna from legal liability from vaccine injuries. To catch up to speed in detail on the EUA vs FDA approved situation, read: Shell Game? There remains no FDA approved COVID vaccine in the United States and Ghost Shot: Pfizer quietly admits it will never manufacture original FDA approved COVID vaccines.
Once described as the cure to the coronavirus, the novel mRNA shots have resulted in catastrophic failure, with a side effect profile exponentially higher than advertised.
Thanks to a fraudulent, deceptive marketing campaign, assisted by top federal officials and high-profile pharmaceutical executives, the drug-makers and the federal government convinced millions of Americans to take shots that were much more dangerous (especially for young men), and much less effective than advertised.
Excited to share that updated analysis from our Phase 3 study with BioNTech also showed that our COVID-19 vaccine was 100% effective in preventing #COVID19 cases in South Africa. 100%! https://t.co/E2ksTJSopU
— Albert Bourla (@AlbertBourla) April 1, 2021
Over the course of COVID mania, Pfizer and Moderna have raked in hundreds of billions of dollars in liability free dollars, enriching their executives and board members beyond their wildest dreams.
Thanks to Big Pharma’s successful regulatory capture of the government healthcare apparatus, and corrupt bureaucrats’ willing compliance, it looks like the mRNA drug cartel will be completely off the hook when it comes to compensating the countless Americans who were harmed by their junk products.
Reprinted with permission from The Dossier.